Moderna (NASDAQ: MRNA) May weekly call option implied volatility is at 216, June is at 133; compared to its 52-week range of 50 to 172 after Moderna said its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients.